India's GlaxoSmithKline Pharma rises on entering country's oncology market

GlaxoSmithKline Pharmaceuticals

25/08/2025 07:58

** GlaxoSmithKline Pharmaceuticals GLAX.NS rises as much as 2.5% to 2,869 rupees; set to gain for second straight session

** Pharma co forays into oncology in India, with Jemperli and Zejula to treat gynaecological cancers

** More than 70,000 shares traded, below 30-day moving avg of 104,281

** GLAX last up ~1%, taking YTD gains to 24.3%

 (Reporting by Meenakshi Maidas in Bengaluru)

 ((meenakshi.maidas@thomsonreuters.com;))